Omicron Replicates Slower In Lungs, Faster In Airways Of COVID-19 Patients: Study
A new study is shedding light on how the new variant of concern thrives in…
Category: Medicine
Opinion: Why the big questions about drug prices are rarely asked: It’s hard to do
Public debate over legislation to allow Medicare to negotiate the price of drugs has been…
Q&A: After finding few answers about her own rare cancer, Corrie Painter is crowdsourcing to fill cancer ‘data vacuum’
In May 2010, Corrie Painter received shocking news: She had angiosarcoma, an extremely rare cancer…
STAT+: Medicine’s first autonomous AI could prevent blindness due to diabetes — if it can reach those most in need
Once feared as a job-erasing technology devoid of clinical nuance, autonomous artificial intelligence in medicine…
Poll: Omicron is forcing Americans to rethink some — but not all — of their holiday plans
Four out of five vaccinated Americans say they will still wear a mask inside public…
.jpg)
STAT+: Health tech’s sky-high projections in 2021 have already been punctured
The health technology sector has seen extraordinary enthusiasm among private and public investors this year….
Virtual Event: The ASH Recap, Live!
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Califf sails through hearing for top FDA job; J.P. Morgan goes virtual after big biotechs pull out
Hello, everyone, and how are you today? We are doing just fine, thank you, since…
Bowing to pressure, J.P. Morgan says its health care conference will be virtual
The J.P. Morgan Healthcare Conference, biotech’s biggest annual conference, will be virtual, the bank said…
Omicron And COVID Boosters: Everything You Need To Know
Early reports suggest omicron causes less severe disease than other variants but it still poses…
Opinion: Listen: A parent on advocating for people with autism who can’t advocate for themselves
Alison Singer learned how to advocate for a child with autism by watching her mother…
STAT+: Biotech investor Eli Casdin on biotech’s bad December
Biotech investors are having some not-so-happy holidays. In the last few months, several major funds…
Opinion: Many states aren’t ready for a 988 crisis line. The deadline is looming
America’s fragile mental health safety net all too often leaves people nowhere to turn but…
How much naloxone is needed to reverse an opioid overdose? New high-dose treatments are raising questions
At a time when a record number of Americans have died from drug overdoses —…
Will we always need Covid-19 boosters? Experts have theories
With the world facing the latest in a seemingly endless stream of coronavirus variants —…
Copy of Will we always need Covid-19 boosters? Experts have theories
With the world facing the latest in a seemingly endless stream of coronavirus variants —…
.jpg)
Califf sails through confirmation hearing for FDA job, despite tensions over opioids
WASHINGTON — Robert Califf escaped largely unscathed from a two-hour hearing Tuesday vetting him to…
STAT+: Moderna, Amgen among biotech heavyweights pulling out of JPM conference over Covid concerns
Some of the biggest names in biotechnology, including Amgen, Moderna, and Sarepta Therapeutics, have pulled…
Telehealth’s 2021 report card & CVS leans on digital health
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
10 Tea Health Benefits You’d Be Surprised To Know
International Tea Day 2021 is here! To help you celebrate, we’re sharing with you the…
Leading Covid-19 experts on the questions they want answered about Omicron
For some Covid experts, what’s most unsettling about the Omicron variant is all the uncertainty…
STAT+: Pharmalittle: Pfizer Covid pill retains 89% efficacy in full study; Senate committee holds hearing on FDA commissioner
Rise and shine, folks, another busy day is on the way. We can tell, thanks…
CDC data indicate Omicron is starting to eat into Delta’s U.S. dominance
The Omicron variant is starting to eat into Delta’s dominance in the United States. The…
STAT+: STAT+ Conversation: The Whitest Medical Specialty
Editor’s note: A livestream of the conversation will be embedded below at 2 p.m. ET….
2-Dose Vaccines Do Not Provide Enough Neutralizing Antibodies Against Omicron: Study
The two-dose formulations of the Pfizer and AstraZeneca vaccines were found to be not that…
Pfizer’s Covid pill remains 89% effective in final analysis, company says
Paxlovid, Pfizer’s pill to treat Covid-19, retained its 89% efficacy at preventing hospitalization and death…
Opinion: FDA’s outdated Birth Control Guide blocks access to the innovations the agency has approved
Every day, women in the United States are routinely denied access to the latest birth…
Watch: A rebel with a cause: As a mentor and a leader, this Black orthopedic surgeon fights to diversify his field
A rare Black orthopedic surgeon in an overwhelmingly white specialty, Eric Carson has spent decades…
STAT+: Oregon wants to get out of covering drugs like Aduhelm in Medicaid
WASHINGTON — Oregon is gearing up to ask the Biden administration if its Medicaid program…
STAT+: Hospitals just dodged a bullet in Democrats’ major spending package. Can they sidestep a bigger one?
WASHINGTON — Hospitals and their lobbyists in Washington just wriggled their way out of a…
Orthopedic surgeons pride themselves on fixing things. Can they fix their own field’s lack of diversity?
This is part two of a STAT investigation on the lack of diversity in orthopedic…
As a Logic song topped the charts, helpline saw more calls and fewer suicides
During the time that a song whose title is the number of a national suicide…
STAT+: Feeling remote: Coalition of pharma regulators look to complement on-site inspections beyond Covid
Nearly two years after the Covid-19 pandemic prompted remote inspections of pharmaceutical production plants, an…
8 Best Ice Cream Alternatives For Christmas 2021 You Can Buy Online
Looking for a healthier ice cream brand you can enjoy during the holidays? Here are…
STAT+: Pharmalittle: Pfizer to pay $6.7 billion for Arena and a bowel disease drug; ASH brings flood of data readouts
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: More potent version of Global Blood sickle-cell drug improves hemoglobin response in small study
Global Blood Therapeutics said Monday that an experimental treatment for sickle cell disease nearly doubled…
STAT+: In a do-over study, Bellus Health cough treatment shows positive results
Results released Monday from a Phase 2 study of a chronic cough treatment being developed…
Rapid Tests Play A Crucial Role In Curbing COVID-19 Infections – Especially As People Gather For The Holidays
The key to rapid antigen testing is to test early in the course of COVID-19…
Figuring Out Omicron – Here’s What Scientists Are Doing Right Now To Understand The New Coronavirus Variant
Scientists around the world have been racing to learn more about the new omicron strain…
Opinion: Don’t let ‘shelved assets’ gather dust. Make them into new lifesaving drugs
Life-science companies have changed the world with the breakthrough vaccines and therapeutics they created —…
We have enough Covid vaccines for most of the world. But rich countries are stockpiling more than they need for boosters
Two years since SARS-CoV-2 first passed into humans, manufacturers have created enough vaccines to inoculate…
The whitest specialty: As medicine strives to close its diversity gaps, one field remains a stubborn outlier
Erica Taylor has a pedigree seemingly built for orthopedic surgery. She comes from National Football…
STAT+: J&J’s new CAR-T therapy shows long-term success, data show
By the time patients with multiple myeloma have gone through four or five different therapies,…
STAT+: Mutations tied to blood cancers and other diseases may surprisingly protect against Alzheimer’s
ATLANTA — When key mutations strike bone marrow stem cells, known as hematopoietic stem cells,…
STAT+: Roche two-armed antibody posts strong tumor responses in lymphoma study, rivaling CAR-T therapy
An off-the-shelf bispecific antibody developed by Roche induced high and durable response rates in patients…
STAT+: Patients with rare blood disorder benefit from Bluebird gene therapy while denied access in Europe
People with severe beta-thalassemia who live in Europe have been denied access to Bluebird Bio’s…
STAT+: Gilead, Bristol jaw over the superiority of rival CAR-T treatments for blood cancer
Competing, bespoke CAR-T cell therapies from Gilead Sciences and Bristol Myers Squibb have each demonstrated…
STAT+: Generic drug makers win a court round as judge temporarily blocks California pay-to-delay law
In a victory for generic drug makers, a federal court judge temporarily blocked a controversial California…
STAT+: Pharmalittle: Fauci unconvinced Omicron-specific vaccines are needed; J&J rebuffed warnings about a diabetes drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: ‘All I want for Christmas’ is higher prices: Congressional report accuses pharma of manipulating Americans for profit
It was the day before Christmas in 2015 and a senior director of national accounts…